CTX-A

N/A

Report date: 2025/01/26 18:21:16

Base Information

Drug NameCTX-A

Drug Alias NameMMP-2 selective chlorotoxin analog (Vascular Research Group)MMP-2 inhibitors (Vascular Research Group)MMP-2 selective chlorotoxin analog (Vascular Research Group)CTX-A

ClassificationBiologics > Protein drugs > ToxinBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionMatrix metalloproteinase-2 inhibitors

TargetsMatrix metalloproteinase-2

Therapy Area/IndicationsPancreatic NeoplasmsGlioblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryHungary

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesVascular Research Group Kft

China Registration ClassN/A

Develop Information

Active CompaniesVascular Research Group Kft

Inactive CompaniesN/A

Active IndicationsPancreatic NeoplasmsGlioblastoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A